Actuate Therapeutics Inc
ACTU | NASDAQ
$0.87
-$0.04 (-4.11%)
Sep 22, 2026, 10:45 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 |
|---|---|---|---|---|
Net Income | -22.23M | -27.29M | -24.74M | -20.16M |
Depreciation & Amortization | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 6.05M | 2M | 423.54K | 654.07K |
Other Working Capital | -2.53M | 2.6M | 1.28M | 1.15M |
Other Non-Cash Items | 20.25K | 2.35M | 123.46K | -20.38K |
Deferred Income Tax | n/a | n/a | n/a | n/a |
Change in Working Capital | -3.05M | 1.1M | 2.57M | 1.73M |
Operating Cash Flow | -19.21M | -21.84M | -21.63M | -17.79M |
Capital Expenditures | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | 5.5M | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -302.83K | -1.93M | n/a | n/a |
Financial Cash Flow | 23.72M | 27.53M | 4.13M | 19.26M |
Net Cash Flow | 4.52M | 5.68M | -17.49M | 1.46M |
Free Cash Flow | -19.21M | -21.84M | -21.63M | -17.79M |
Adj. Free Cash Flow | -25.25M | -23.84M | -22.05M | -18.45M |
Maintenance CapEx | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a |
Owner Earnings | -19.21M | -21.84M | -21.63M | -17.79M |
Add to Watchlist
Select watchlists to add or remove ACTU